Literature DB >> 9647736

Structural characterization and mapping of the normal epithelial cell-specific 1 gene.

L Luo1, J A Herbrick, S W Scherer, B Beatty, J Squire, E P Diamandis.   

Abstract

The normal epithelial cell-specific 1 (NES1) gene is a recently identified novel serine protease-like gene which is down-regulated during breast cancer progression. The gene product has 34-42% identity with the members of three distinct serine protease families: the trypsin-like family, activators of kringle domain-containing growth factors, and the kallikrein family (X. L. Liu et al., (1996) Cancer Res 56, 3371-3379). Although the cDNA of this gene has been cloned, its genomic structure and chromosomal position are not as yet known. Here, we report the genomic characterization and mapping of the NES1 gene. By subcloning and sequencing a PAC clone containing the complete NES1 gene, we were able to characterize the structure of this gene. The NES1 gene spans 5.5 kb and is composed of five coding exons and one untranslated exon. The positions of the introns were similar to trypsinogen, prostate specific antigen (PSA), and tissue plasminogen activator (TPA). NES1 gene was also localized with somatic cell mapping, radiation hybrid mapping, and fluorescence in situ hybridization techniques to chromosome 19q13.3-q13.4, the same region where the human kallikrein gene family resides. Taken together, our results suggest that the NES1 gene originates from the same ancestor as trypsinogen, PSA, and TPA, but remains in close proximity to PSA.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9647736     DOI: 10.1006/bbrc.1998.8793

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Expression analysis and clinical evaluation of kallikrein-related peptidase 10 (KLK10) in colorectal cancer.

Authors:  Maroulio Talieri; Dimitra K Alexopoulou; Andreas Scorilas; Dimitris Kypraios; Niki Arnogiannaki; Marina Devetzi; Matina Patsavela; Dimitris Xynopoulos
Journal:  Tumour Biol       Date:  2011-04-12

2.  Amplification of human genomic DNA sequences with polymerase chain reaction using a single oligonucleotide primer.

Authors:  L Luo; E P Diamandis
Journal:  J Clin Lab Anal       Date:  1999       Impact factor: 2.352

3.  Molecular cloning and characterization of prostase, an androgen-regulated serine protease with prostate-restricted expression.

Authors:  P S Nelson; L Gan; C Ferguson; P Moss; R Gelinas; L Hood; K Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

4.  Rare Variants in Novel Candidate Genes Associated With Nonsyndromic Patent Ductus Arteriosus Identified With Whole-Exome Sequencing.

Authors:  Ying Gao; Dan Wu; Bo Chen; Yinghui Chen; Qi Zhang; Pengjun Zhao
Journal:  Front Genet       Date:  2022-06-06       Impact factor: 4.772

5.  The canine kallikrein-related peptidases 9 and 10: structural characterization and expression in mammary cancer.

Authors:  Katerina Angelopoulou; George S Karagiannis
Journal:  Mamm Genome       Date:  2009-12-02       Impact factor: 2.957

6.  Suppression of gastric cancer growth by baculovirus vector-mediated transfer of normal epithelial cell specific-1 gene.

Authors:  Wei Huang; Xiang-Long Tian; Yun-Lin Wu; Jie Zhong; Li-Fen Yu; Sheng-Ping Hu; Biao Li
Journal:  World J Gastroenterol       Date:  2008-10-14       Impact factor: 5.742

7.  Expression of the normal epithelial cell-specific 1 (NES1; KLK10) candidate tumour suppressor gene in normal and malignant testicular tissue.

Authors:  L Y Luo; E R Rajpert-De Meyts; K Jung; E P Diamandis
Journal:  Br J Cancer       Date:  2001-07-20       Impact factor: 7.640

8.  Higher expression of human kallikrein 10 in breast cancer tissue predicts tamoxifen resistance.

Authors:  L-Y Luo; E P Diamandis; M P Look; A P Soosaipillai; J A Foekens
Journal:  Br J Cancer       Date:  2002-06-05       Impact factor: 7.640

9.  NES1/KLK10 gene represses proliferation, enhances apoptosis and down-regulates glucose metabolism of PC3 prostate cancer cells.

Authors:  Jiajia Hu; Hu Lei; Xiaochun Fei; Sheng Liang; Hanzhang Xu; Dongjun Qin; Yue Wang; Yingli Wu; Biao Li
Journal:  Sci Rep       Date:  2015-11-30       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.